Cellis Competitors and Similar CompaniesClear all

Cellis's competitors and similar companies include Sanochemia Pharmazeutika, BioInvent, Erasca and Calviri.
Cellis
Cellis
Cellis is a company that develops therapeutic and diagnostic solutions with a focus on nanotechnology, oncology, and molecular biology.
Sanochemia Pharmazeutika
Sanochemia Pharmazeutika
Sanochemia Pharmazeutika is a specialty pharmaceutical company that develops and manufactures drugs and diagnostics in the areas of neurodegeneration, pain, and oncology.
BioInvent
BioInvent
BioInvent focuses on the discovery and development of antibody-based drugs against cancer.
Erasca
Erasca
Erasca is a clinical-stage precision oncology company that discovers, develops, and commercializes therapies for cancer patients.
Calviri
Calviri
Calviri is a company that develops diagnostic and therapeutic products, as well as vaccines aimed to prevent cancer.
Founding Date
Founding Date
2015
Founding Date
1990
Founding Date
1997
Founding Date
2018
Founding Date
2018
Type
Type
Private
Type
Private
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
Zürich, CH HQ
Warsaw, PL
Locations
Neufeld an der Leitha, AT HQ
Neuss, DE
Zug, CH
City Of Bristol, GB
Charlotte, US
Locations
Lund, SE HQ
Locations
San Diego, US HQ
Locations
Phoenix, US HQ
Employees
Employees
23
Employees
200
Employees
118
Employees
103
Employees
16
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
285.9 m
Valuation ($)
791 m
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
€33m (FY, 2018)
Revenue (est.)
kr226.5m (FY, 2025)
Revenue (est.)
N/A
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
€18.7m (FY, 2018)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
€15.3m (FY, 2018)
Gross profit
kr226.6m (FY, 2025)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
N/A
Net income
(€13.3m) (FY, 2018)
Net income
(kr332.9m) (FY, 2025)
Net income
($124.5m) (FY, 2025)
Net income
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 300m
Total funding raised
$ 2.3m
For sources of this data, please see the company profile

View Company Profiles

Sanochemia Pharmazeutika
HQ
Neufeld an der Leitha, AT
Employees
200

Sanochemia Pharmazeutika is a specialty pharmaceutical company that develops and manufactures drugs and diagnostics in the areas of neurodegeneration, pain, and oncology.

View company
BioInvent
HQ
Lund, SE
Employees
118

BioInvent focuses on the discovery and development of antibody-based drugs against cancer.

View company
Erasca
HQ
San Diego, US
Employees
103

Erasca is a clinical-stage precision oncology company that discovers, develops, and commercializes therapies for cancer patients.

View company
Calviri
HQ
Phoenix, US
Employees
16

Calviri is a company that develops diagnostic and therapeutic products, as well as vaccines aimed to prevent cancer.

View company